Our team is well-coordinated in providing a streamlined hit to lead transition while working closely with you on a meaningful and dedicated screening system to allow for efficient hit expansion. InnoSer provides robust and unbiased experimental design, methodology, analysis, interpretation, and reporting of results to support your journey into the Lead Optimization phase. 

We support your needs with customized solutions

We offer many of these studies, with increasing sample sizes, all the way from early research leading to informed and translatable late preclinical research. 

We offer hit to lead development in a range of therapeutic fields and molecular entities using flexible and customizable hit to lead development steps. InnoSer provides functional assays, cell models, and in vivo methods to gain a robust overview of the strengths and optimization requirements of the investigational drug.  

Our in-house expertise lies in immuno-oncology, cardio-metabolic, neurology, and nephrology. However, our established network of connections provides our clients with proactive, timely, and comprehensive services to reach therapeutic success in a range of therapeutic areas. 

By providing a fully integrated solution, your project’s needs drive the services we provide and may feature one or more of the following services: 

Pharmacology 

• Proof-of-Concept Studies 
• Preliminary dose range finding (MTD) 

Toxicology 

• 単回投与毒性 
• 反復投与毒性 
• 毒性動態学 

Biocompatibility

Pharmacometrics